TYK2 — Drug Target

All drugs that target TYK2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

TYK2 inhibitor

Phase 3 pipeline (1)

• Placebo to match deucravacitinib · Takeda · TYK2 inhibitor · Immunology
  Deucravacitinib is a small molecule that acts as a selective tyrosine kinase 2 (TYK2) inhibitor.